nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical presentation and staging of Hodgkin lymphoma
|
Gallamini, Andrea |
|
2016 |
53 |
3 |
p. 148-154 7 p. |
artikel |
2 |
Hodgkin lymphoma in the elderly, pregnant, and HIV-infected
|
Bachanova, Veronika |
|
2016 |
53 |
3 |
p. 203-208 6 p. |
artikel |
3 |
Hodgkin lymphoma: Introduction
|
Engert, Andreas |
|
2016 |
53 |
3 |
p. 137-138 2 p. |
artikel |
4 |
Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance
|
Ng, Andrea K. |
|
2016 |
53 |
3 |
p. 209-215 7 p. |
artikel |
5 |
Hodgkin lymphoma: Pathology and biology
|
Mathas, Stephan |
|
2016 |
53 |
3 |
p. 139-147 9 p. |
artikel |
6 |
Masthead
|
|
|
2016 |
53 |
3 |
p. IFC- 1 p. |
artikel |
7 |
Nodular lymphocyte-predominant Hodgkin lymphoma
|
Savage, Kerry J. |
|
2016 |
53 |
3 |
p. 190-202 13 p. |
artikel |
8 |
Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results
|
Younes, Anas |
|
2016 |
53 |
3 |
p. 186-189 4 p. |
artikel |
9 |
outside front cover
|
|
|
2016 |
53 |
3 |
p. OFC- 1 p. |
artikel |
10 |
Prognostic factors in Hodgkin lymphoma
|
Bröckelmann, Paul J. |
|
2016 |
53 |
3 |
p. 155-164 10 p. |
artikel |
11 |
Similarity of fractionated versus single dose(s) of gemtuzumab ozogamicin as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients
|
Peterlin, Pierre |
|
2016 |
53 |
3 |
p. 216-217 2 p. |
artikel |
12 |
Table of Contents
|
|
|
2016 |
53 |
3 |
p. A1-A2 nvt p. |
artikel |
13 |
Treatment of advanced-stage Hodgkin lymphoma
|
Vassilakopoulos, Theodoros P. |
|
2016 |
53 |
3 |
p. 171-179 9 p. |
artikel |
14 |
Treatment of early-stage Hodgkin lymphoma
|
Engert, Andreas |
|
2016 |
53 |
3 |
p. 165-170 6 p. |
artikel |
15 |
Treatment of relapsed and refractory Hodgkin Lymphoma
|
von Tresckow, Bastian |
|
2016 |
53 |
3 |
p. 180-185 6 p. |
artikel |